Tag Archives: PureTech Health

July, 2018

20 July
PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides

BOSTON–(BUSINESS WIRE)–PureTech Health plc (LSE: PRTC) (“PureTech Health”), a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut (BIG) Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech’s milk-derived exosome platform technology for the oral …
Share

11 May
PureTech Launches Alivio Therapeutics for Novel Approach for Treating Inflammatory Disease

BOSTON–(BUSINESS WIRE)–PureTech Health plc (“PureTech,” LSE: PRTC), a cross-disciplinary healthcare company tackling fundamental healthcare needs, today announces the launch of Alivio Therapeutics, which is developing a novel technology for the targeted treatment of inflammatory disorders. The technology is based on an innovative hydrogel material that is designed to adhere to …
Share